The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder : A Second Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
- Author
- MARCUS, Ronald N1 ; MCQUADE, Robert D2 ; CARSON, William H2 ; HENNICKEN, Delphine3 ; FAVA, Maurizio4 ; SIMON, Jeffrey S5 ; TRIVEDI, Madhukar H6 ; THASE, Michael E7 ; BERMAN, Robert M1
[1] Bristol-Myers Squibb, Wallingford, CT, United States
[2] Otsuka Pharmaceutical Development & Commercialization, Inc, Princeton, NJ, United States
[3] Bristol-Myers Squibb, Braine-l'Alleud, Belgium
[4] Depression Clinical and Research Program, Massachusetts General Hospital, Boston, MA, United States
[5] Northbrooke Research Center, Brown Deer, WI, United States
[6] The University of Texas Southwestern Medical Center, Dallas, TX, United States
[7] Department of Psychiatry, University of Pittsburgh Medical Center, University of Pennsylvania School of Medicine, and the Philadelphia Veterans Affairs Medical Center, Pennsylvania, PA, United States - Source
Journal of clinical psychopharmacology. 2008, Vol 28, Num 2, pp 156-165, 10 p ; ref : 31 ref
- CODEN
- JCPYDR
- ISSN
- 0271-0749
- Scientific domain
- Pharmacology drugs; Psychology, psychopathology, psychiatry
- Publisher
- Lippincott Williams & Wilkins, Hagerstown, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Aripiprazole Efficacité Etat dépressif Etude double insu Homme Neuroleptique Placebo Psychotrope Randomisation Sécurité Toxicité Traitement adjuvant Agoniste partiel Antagoniste Quinolinone dérivé Récepteur dopaminergique D2 Récepteur sérotoninergique 5-HT1A Récepteur sérotoninergique 5-HT2A Trouble de l'humeur
- Keyword (en)
- Aripiprazole Efficiency Depression Double blind study Human Neuroleptic Placebo Psychotropic Randomization Safety Toxicity Adjuvant treatment Partial agonist Antagonist Quinolinone derivatives D2 Dopamine receptor 5-HT1A Serotonine receptor 5-HT2A serotonin receptor Mood disorder
- Keyword (es)
- Aripiprazol Eficacia Estado depresivo Estudio doble ciego Hombre Neuroléptico Placebo Psicotropo Aleatorización Seguridad Toxicidad Tratamiento adyuvante Agonista parcial Antagonista Quinolinona derivada Receptor dopaminérgico D2 Receptor serotoninérgico 5-HT1A Receptor serotoninérgico 5-HT2A Trastorno humor
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02B Neuropharmacology / 002B02B03 Psycholeptics: tranquillizer, neuroleptic.
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B18 Psychopathology. Psychiatry / 002B18C Adult and adolescent clinical studies / 002B18C07 Mood disorders / 002B18C07A Depression
- Francis
- 770 Psychology. Psychoanalysis. Psychiatry / 770-D Psychopathology. Psychiatry / 770-D03 Adult and adolescent clinical studies / 770-D03G Mood disorders / 770-D03G01 Depression
- Francis
- 770 Psychology. Psychoanalysis. Psychiatry / 770-E Psychopharmacology / 770-E03 Psycholeptics: tranquillizer, neuroleptic…
- Discipline
- Pharmacological treatments Psychopathology. Psychiatry. Clinical psychology
- Origin
- Inist-CNRS
- Database
- FRANCIS ; PASCAL
- INIST identifier
- 20196792
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1097/JCP.0b013e31816774f9 
https://dx.doi.org/10.1097/JCP.0b013e31816774f9
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1097\/JCP.0b013e31816774f9\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:165:\"The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder : A Second Multicenter, Randomized, Double-Blind, Placebo-Controlled Study\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Journal of clinical psychopharmacology\";s:9:\"\u0000*\u0000stitle\";s:24:\"J. clin. psychopharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"28\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"156\";s:8:\"\u0000*\u0000epage\";s:3:\"165\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0271-0749\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"MARCUS\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Ronald N\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:17:\"MCQUADE, Robert D\";i:1;s:17:\"CARSON, William H\";i:2;s:19:\"HENNICKEN, Delphine\";i:3;s:14:\"FAVA, Maurizio\";i:4;s:16:\"SIMON, Jeffrey S\";i:5;s:19:\"TRIVEDI, Madhukar H\";i:6;s:16:\"THASE, Michael E\";i:7;s:16:\"BERMAN, Robert M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JCPYDR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:165:\"The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder : A Second Multicenter, Randomized, Double-Blind, Placebo-Controlled Study\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1097\/JCP.0b013e31816774f9\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:165:\"The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder : A Second Multicenter, Randomized, Double-Blind, Placebo-Controlled Study\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Journal of clinical psychopharmacology\";s:9:\"\u0000*\u0000stitle\";s:24:\"J. clin. psychopharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"28\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"156\";s:8:\"\u0000*\u0000epage\";s:3:\"165\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0271-0749\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"MARCUS\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Ronald N\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:17:\"MCQUADE, Robert D\";i:1;s:17:\"CARSON, William H\";i:2;s:19:\"HENNICKEN, Delphine\";i:3;s:14:\"FAVA, Maurizio\";i:4;s:16:\"SIMON, Jeffrey S\";i:5;s:19:\"TRIVEDI, Madhukar H\";i:6;s:16:\"THASE, Michael E\";i:7;s:16:\"BERMAN, Robert M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JCPYDR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:165:\"The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder : A Second Multicenter, Randomized, Double-Blind, Placebo-Controlled Study\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:28:\"10.1097\/JCP.0b013e31816774f9\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1097\/JCP.0b013e31816774f9\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:165:\"The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder : A Second Multicenter, Randomized, Double-Blind, Placebo-Controlled Study\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Journal of clinical psychopharmacology\";s:9:\"\u0000*\u0000stitle\";s:24:\"J. clin. psychopharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"28\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"156\";s:8:\"\u0000*\u0000epage\";s:3:\"165\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0271-0749\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"MARCUS\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Ronald N\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:17:\"MCQUADE, Robert D\";i:1;s:17:\"CARSON, William H\";i:2;s:19:\"HENNICKEN, Delphine\";i:3;s:14:\"FAVA, Maurizio\";i:4;s:16:\"SIMON, Jeffrey S\";i:5;s:19:\"TRIVEDI, Madhukar H\";i:6;s:16:\"THASE, Michael E\";i:7;s:16:\"BERMAN, Robert M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JCPYDR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:165:\"The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder : A Second Multicenter, Randomized, Double-Blind, Placebo-Controlled Study\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1097\/JCP.0b013e31816774f9\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:165:\"The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder : A Second Multicenter, Randomized, Double-Blind, Placebo-Controlled Study\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Journal of clinical psychopharmacology\";s:9:\"\u0000*\u0000stitle\";s:24:\"J. clin. psychopharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"28\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"156\";s:8:\"\u0000*\u0000epage\";s:3:\"165\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0271-0749\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"MARCUS\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Ronald N\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:17:\"MCQUADE, Robert D\";i:1;s:17:\"CARSON, William H\";i:2;s:19:\"HENNICKEN, Delphine\";i:3;s:14:\"FAVA, Maurizio\";i:4;s:16:\"SIMON, Jeffrey S\";i:5;s:19:\"TRIVEDI, Madhukar H\";i:6;s:16:\"THASE, Michael E\";i:7;s:16:\"BERMAN, Robert M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JCPYDR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:165:\"The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder : A Second Multicenter, Randomized, Double-Blind, Placebo-Controlled Study\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1097\/JCP.0b013e31816774f9\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:165:\"The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder : A Second Multicenter, Randomized, Double-Blind, Placebo-Controlled Study\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Journal of clinical psychopharmacology\";s:9:\"\u0000*\u0000stitle\";s:24:\"J. clin. psychopharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"28\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"156\";s:8:\"\u0000*\u0000epage\";s:3:\"165\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0271-0749\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"MARCUS\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Ronald N\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:17:\"MCQUADE, Robert D\";i:1;s:17:\"CARSON, William H\";i:2;s:19:\"HENNICKEN, Delphine\";i:3;s:14:\"FAVA, Maurizio\";i:4;s:16:\"SIMON, Jeffrey S\";i:5;s:19:\"TRIVEDI, Madhukar H\";i:6;s:16:\"THASE, Michael E\";i:7;s:16:\"BERMAN, Robert M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JCPYDR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:165:\"The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder : A Second Multicenter, Randomized, Double-Blind, Placebo-Controlled Study\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
